GlassScriptPhysician profile
Michael A Bogdan
NPI 1881629103
$3,549.45
in general payments reported to CMS, 2019-2025
12 companies · $479 in 2025
The $479 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2021: $371 · 2022: $431 · 2023: $852 · 2024: $1,219 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,549.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $695.96 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $650.47 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Tela Bio, INC. | $630.66 | 2023-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Sientra, INC. | $464.98 | 2021-2022 | |
| Acera Surgical, INC. | $400.68 | 2023-2024 | Restrata Wound Matrix |
| Allergan, INC. | $207.22 | 2021-2022 | |
| Avita Medical Americas, LLC | $148.54 | 2024 | |
| Medical Device Business Services, INC. | $124.32 | 2025 | Dermabond |
| Baxter Healthcare | $105.91 | 2025 | Artiss |
| Galderma Laboratories, L.P. | $73.66 | 2022-2025 | |
| Revance Therapeutics, INC. | $27.86 | 2025 | Daxxify |
| Integra Lifesciences Corporation | $19.19 | 2024 | Integra, Integra Dermal Regeneration Template, Surgimend |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bogdan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.